| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Division of Environmental Health Sciences, Joseph L. Mailman School of Public Health, Columbia University, New York, New York 10032 [D. T., L. A. M., Y. H., S. C., W-Y. T., F. P. P.]; Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey SM2 5NG, United Kingdom [D. H. P., K. J. C., M. N. S.]; and Channing Laboratory, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts 02115 [M. S., J. M.]
In this matched case-control study nested within the prospective Physicians Health Study, we evaluated whether DNA damage in blood samples collected at enrollment significantly predicted risk, consistent with our hypothesis that cases have greater biological susceptibility to polycyclic aromatic hydrocarbons and other aromatic tobacco carcinogens. The subjects were 89 cases of primary lung cancer and 173 controls, all males, matched on smoking, age, and duration of follow-up. Aromatic-DNA adducts were measured in WBCs by the nuclease P1-enhanced 32P-postlabeling method that primarily detects smoking-related adducts. Among current smokers, but not former or nonsmokers, there was a significant increase in mean adduct levels of cases compared with controls (11.04 versus 5.63; P = 0.03). "Healthy" current smokers who had elevated levels of aromatic DNA adducts in WBCs were approximately three times more likely to be diagnosed with lung cancer 113 years later than current smokers with lower adduct concentrations (odds ratio, 2.98; 95% confidence interval, 1.058.42; P = 0.04). We were not able to discern case-control differences in former smokers and nonsmokers. The findings are of interest because they suggest that individuals who become cases have greater biological susceptibility to tobacco carcinogens, a biological difference, which manifests most clearly while exposure is ongoing.
This article has been cited by other articles:
![]() |
F. Veglia, S. Loft, G. Matullo, M. Peluso, A. Munnia, F. Perera, D. H. Phillips, D. Tang, H. Autrup, O. Raaschou-Nielsen, et al. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis Carcinogenesis, May 1, 2008; 29(5): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 547 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Munnia, F. Saletta, A. Allione, S. Piro, M. Confortini, G. Matullo, and M. Peluso 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies Mutagenesis, November 1, 2007; 22(6): 381 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1954 - 1965. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Castano-Vinyals, G. Talaska, N. Rothman, J. Alguacil, M. Garcia-Closas, M. Dosemeci, K. P. Cantor, N. Malats, F. X. Real, D. Silverman, et al. Bulky DNA Adduct Formation and Risk of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2155 - 2159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gunter, R. L. Divi, M. Kulldorff, R. Vermeulen, K. J. Haverkos, M. M. Kuo, P. Strickland, M. C. Poirier, N. Rothman, and R. Sinha Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma Carcinogenesis, July 1, 2007; 28(7): 1426 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Besaratinia and G. P. Pfeifer Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis Carcinogenesis, August 1, 2006; 27(8): 1526 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera, D. Tang, P. Brandt-Rauf, R. M. Santella, L. V. A. Mooney, Y.-H. Tu, I. Bendkowska, and D. A. Bell Lack of Associations among Cancer and Albumin Adducts, ras p21 Oncoprotein Levels, and CYP1A1, CYP2D6, NAT1, and NAT2 in a Nested Case-Control Study of Lung Cancer within the Physicians' Health Study. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1417 - 1419. [Full Text] [PDF] |
||||
![]() |
K. L. Lockett, M.C. Hall, P. E. Clark, S.-C. Chuang, B. Robinson, H.-Y. Lin, L.J. Su, and J. J. Hu DNA damage levels in prostate cancer cases and controls Carcinogenesis, June 1, 2006; 27(6): 1187 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Ketelslegers, R. W.H. Gottschalk, R. W.L. Godschalk, A. M. Knaapen, F. J. van Schooten, R. F.M.H. Vlietinck, J. C.S. Kleinjans, and J. H.M. van Delft Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 624 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Thurston, G. Liu, D. P. Miller, and D. C. Christiani Modeling Lung Cancer Risk in Case-Control Studies Using a New Dose Metric of Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2296 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Airoldi, P. Vineis, A. Colombi, L. Olgiati, C. Dell'Osta, R. Fanelli, L. Manzi, F. Veglia, H. Autrup, A. Dunning, et al. 4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2118 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peluso, A. Munnia, G. Hoek, M. Krzyzanowski, F. Veglia, L. Airoldi, H. Autrup, A. Dunning, S. Garte, P. Hainaut, et al. DNA Adducts and Lung Cancer Risk: A Prospective Study Cancer Res., September 1, 2005; 65(17): 8042 - 8048. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Wild Complementing the Genome with an "Exposome": The Outstanding Challenge of Environmental Exposure Measurement in Molecular Epidemiology Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1847 - 1850. [Full Text] [PDF] |
||||
![]() |
A. G. Rundle, P. Vineis, and H. Ahsan Design Options for Molecular Epidemiology Research within Cohort Studies Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1899 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Godschalk, J. Hogervorst, H. Albering, P. Mercelina-Roumans, F.-J. van Schooten, J. de Haan, and J. Kleinjans Interaction between cadmium and aromatic DNA adducts in hprt mutagenesis during foetal development Mutagenesis, May 1, 2005; 20(3): 181 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Perera, D. Tang, R. Whyatt, S. A. Lederman, and W. Jedrychowski DNA Damage from Polycyclic Aromatic Hydrocarbons Measured by Benzo[a]pyrene-DNA Adducts in Mothers and Newborns from Northern Manhattan, The World Trade Center Area, Poland, and China Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle Molecular Epidemiology of Physical Activity and Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mooney, A. M. Madsen, D. Tang, M. A. Orjuela, W.-Y. Tsai, E. R. Garduno, and F. P. Perera Antioxidant Vitamin Supplementation Reduces Benzo(a)pyrene-DNA Adducts and Potential Cancer Risk in Female Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Georgiadis, J. Topinka, D. Vlachodimitropoulos, M. Stoikidou, M. Gioka, G. Stephanou, H. Autrup, N. A. Demopoulos, K. Katsouyanni, R. Sram, et al. Interactions between CYP1A1 polymorphisms and exposure to environmental tobacco smoke in the modulation of lymphocyte bulky DNA adducts and chromosomal aberrations Carcinogenesis, January 1, 2005; 26(1): 93 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Rybicki, A. Rundle, A. T. Savera, S. S. Sankey, and D. Tang Polycyclic Aromatic Hydrocarbon-DNA Adducts in Prostate Cancer Cancer Res., December 15, 2004; 64(24): 8854 - 8859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peluso, M. Neri, G. Margarino, C. Mereu, A. Munnia, M. Ceppi, M. Buratti, R. Felletti, F. Stea, R. Quaglia, et al. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms Carcinogenesis, December 1, 2004; 25(12): 2459 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Van Schooten, A. W. Boots, A. M. Knaapen, R. W. L. Godschalk, L. M. Maas, P. J. A. Borm, M. Drent, and J. A. Jacobs Myeloperoxidase (MPO) -463G->A Reduces MPO Activity and DNA Adduct Levels in Bronchoalveolar Lavages of Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 828 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palli, G. Masala, M. Peluso, L. Gaspari, V. Krogh, A. Munnia, S. Panico, C. Saieva, R. Tumino, P. Vineis, et al. The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects Carcinogenesis, April 1, 2004; 25(4): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benhamou, A. Laplanche, B. Guillonneau, A. Mejean, F. Desgrandchamps, C. Schrameck, V. Degieux, and F. Perin DNA adducts in normal bladder tissue and bladder cancer risk Mutagenesis, September 1, 2003; 18(5): 445 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gackowski, E. Speina, M. Zielinska, J. Kowalewski, R. Rozalski, A. Siomek, T. Paciorek, B. Tudek, and R. Olinski Products of Oxidative DNA Damage and Repair as Possible Biomarkers of Susceptibility to Lung Cancer Cancer Res., August 15, 2003; 63(16): 4899 - 4902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rundle and S. Schwartz Issues in the Epidemiological Analysis and Interpretation of Intermediate Biomarkers Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 491 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palli, G. Masala, P. Vineis, S. Garte, C. Saieva, V. Krogh, S. Panico, R. Tumino, A. Munnia, E. Riboli, et al. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults Carcinogenesis, April 1, 2003; 24(4): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Veglia, G. Matullo, and P. Vineis Bulky DNA Adducts and Risk of Cancer: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 157 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Divi, F. A. Beland, P. P. Fu, L. S. Von Tungeln, B. Schoket, J. E. Camara, M. Ghei, N. Rothman, R. Sinha, and M. C. Poirier Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring Carcinogenesis, December 1, 2002; 23(12): 2043 - 2049. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Godschalk, J. Nair, F.J. van Schooten, A. Risch, P. Drings, K. Kayser, H. Dienemann, and H. Bartsch Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking Carcinogenesis, December 1, 2002; 23(12): 2081 - 2086. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Shields Tobacco Smoking, Harm Reduction, and Biomarkers J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Husgafvel-Pursiainen Molecular biomarkers in studies on environmental cancer J Epidemiol Community Health, October 1, 2002; 56(10): 730 - 731. [Full Text] [PDF] |
||||
![]() |
F. Perera, K. Hemminki, W. Jedrychowski, R. Whyatt, U. Campbell, Y. Hsu, R. Santella, R. Albertini, and J. P. O'Neill In Utero DNA Damage from Environmental Pollution Is Associated with Somatic Gene Mutation in Newborns Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1134 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera, L. A. Mooney, M. Stampfer, D. H. Phillips, D. A. Bell, A. Rundle, S. Cho, W.-Y. Tsai, J. Ma, A. Blackwood, et al. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study Carcinogenesis, October 1, 2002; 23(10): 1641 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Besaratinia, L.M. Maas, E.M.C. Brouwer, E.J.C. Moonen, T.M.C.M. De Kok, G.J. Wesseling, S. Loft, J.C.S. Kleinjans, and F.J. Van Schooten A molecular dosimetry approach to assess human exposure to environmental tobacco smoke in pubs Carcinogenesis, July 1, 2002; 23(7): 1171 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Airoldi, F. Orsi, C. Magagnotti, R. Coda, D. Randone, G. Casetta, M. Peluso, A. Hautefeuille, C. Malaveille, and P. Vineis Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies Carcinogenesis, May 1, 2002; 23(5): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |